A Phase 1, Open-label, Randomized, Two-period, Two-treatment, Crossover Study to Evaluate the Effect of Bexagliflozin on the Pharmacokinetics of Digoxin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Bexagliflozin (Primary) ; Digoxin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Theracos
- 21 Sep 2017 Status changed to completed.
- 20 Jul 2017 Planned End Date changed from 17 Aug 2017 to 17 Sep 2017.
- 20 Jul 2017 Planned primary completion date changed from 17 Aug 2017 to 17 Sep 2017.